If the crackdown on pharma’s TV ads and subsequent extension to social media has underscored anything, it’s that brands need ...

While the scale of the currency headwinds in Roche’s first-quarter financial update caught many off guard, the company’s ...

President Donald Trump's administration has reclassified medical marijuana as a less dangerous drug. The order, signed ...

The new "Michael" movie recreates the traumatizing moment when Michael Jackson's hair caught on fire while filming a Pepsi ...

The deal involves Regeneron lowering the prices of current and all future drugs on Medicaid, according to Trump. It also ...

Acting Attorney General Todd Blanche issues a final order moving medical cannabis products to Schedule III, following a 2025 ...

Although drug ads enjoy First Amendment constitutional protection, I still think they are a bad idea. We shouldn’t be selling medicine like we sell mattresses, writes Dr. Michael Kirsh in a guest ...

Travere Therapeutics rated a Buy after Filspari’s FDA approval for FSGS—only therapy available. Read TVTX's valuation upside, ...

A string of ASX-listed drug developers is due to release company-making – or breaking – pivotal clinical study results in ...

CVS has spent millions to kill a bill requiring pharmacy benefit managers to divest from pharmacies. Senators passed it with ...

New drugs approved in 2025 are poised to significantly improve the management of motion sickness, acute pain, urinary tract infections (UTIs), and chronic spontaneous urticaria. Gerald W. Smetana, MD, ...

CBP officers intercepted 32 packages of suspected cocaine worth over $1.1 million at a Texas border crossing in a massive ...